McLoughlin Rachel M, Hurst Suzanne M, Nowell Mari A, Harris Dean A, Horiuchi Sankichi, Morgan Llinos W, Wilkinson Thomas S, Yamamoto Naoki, Topley Nicholas, Jones Simon A
Cardiff School of Biosciences, Cardiff University, Cardiff, Wales, United Kingdom.
J Immunol. 2004 May 1;172(9):5676-83. doi: 10.4049/jimmunol.172.9.5676.
Interleukin-6 signaling via its soluble receptor (sIL-6R) differentially regulates inflammatory chemokine expression and leukocyte apoptosis to coordinate transition from neutrophil to mononuclear cell infiltration. sIL-6R activities may, however, be influenced in vivo by the occurrence of two sIL-6R isoforms that are released as a consequence of differential mRNA splicing (DS) or proteolytic cleavage (PC) of the cognate IL-6R (termed DS- and PC-sIL-6R). Using human peritoneal mesothelial cells and a murine model of peritoneal inflammation, studies described in this work have compared the ability of both isoforms to regulate neutrophil recruitment. In this respect, DS- and PC-sIL-6R were comparable in their activities; however, these studies emphasized that IL-6 trans signaling differentially controls neutrophil-activating CXC chemokine expression. In vitro, stimulation of mesothelial cells with IL-6 in combination with either DS-sIL-6R or PC-sIL-6R showed no induction of CXC chemokine ligand (CXCL)1 (GRO alpha) and CXCL8 (IL-8), whereas both isoforms enhanced CXCL5 (ENA-78) and CXCL6 (granulocyte chemotactic protein-2) expression. Moreover, when complexed with IL-6, both isoforms specifically inhibited the IL-1 beta-induced secretion of CXCL8. These findings were paralleled in vivo, in which induction of peritoneal inflammation in IL-6-deficient (IL-6(-/-)) mice resulted in enhanced keratinocyte-derived chemokine and macrophage-inflammatory protein-2 (the murine equivalent of CXCL1 and CXCL8) levels, but reduced LPS-induced CXC chemokine (the murine equivalent of CXCL5) expression. Reconstitution of IL-6 signaling in IL-6(-/-) mice with IL-6 and its soluble receptor isoforms corrected this chemokine imbalance and suppressed overall neutrophil infiltration. These data confirm that sIL-6R-mediated signaling primarily limits neutrophil influx; however, induction of CXCL5 and CXCL6 may regulate other neutrophil responses.
白细胞介素-6通过其可溶性受体(sIL-6R)发出的信号以不同方式调节炎性趋化因子的表达和白细胞凋亡,从而协调从中性粒细胞浸润到单核细胞浸润的转变。然而,sIL-6R的活性在体内可能会受到两种sIL-6R亚型的影响,这两种亚型是同源白细胞介素-6受体(IL-6R)通过差异mRNA剪接(DS)或蛋白水解切割(PC)释放产生的(分别称为DS-sIL-6R和PC-sIL-6R)。利用人腹膜间皮细胞和腹膜炎症小鼠模型,本研究中描述的实验比较了这两种亚型调节中性粒细胞募集的能力。在这方面,DS-sIL-6R和PC-sIL-6R的活性相当;然而,这些研究强调白细胞介素-6转导信号以不同方式控制激活中性粒细胞的CXC趋化因子的表达。在体外,用白细胞介素-6联合DS-sIL-6R或PC-sIL-6R刺激间皮细胞,未诱导CXC趋化因子配体(CXCL)1(GROα)和CXCL8(白细胞介素-8)的产生,而两种亚型均增强了CXCL5(ENA-78)和CXCL6(粒细胞趋化蛋白-2)的表达。此外,当与白细胞介素-6复合时,两种亚型均特异性抑制白细胞介素-1β诱导的CXCL8分泌。这些结果在体内也得到了印证,在白细胞介素-6缺陷(IL-6(-/-))小鼠中诱导腹膜炎症会导致角质形成细胞衍生趋化因子和巨噬细胞炎性蛋白-2(小鼠体内相当于CXCL1和CXCL8)水平升高,但脂多糖诱导的CXC趋化因子(小鼠体内相当于CXCL5)表达降低。用白细胞介素-6及其可溶性受体亚型重建IL-6(-/-)小鼠的白细胞介素-6信号可纠正这种趋化因子失衡并抑制整体中性粒细胞浸润。这些数据证实,sIL-6R介导的信号主要限制中性粒细胞流入;然而,CXCL5和CXCL6的诱导可能调节中性粒细胞的其他反应。